Free Trial
LON:NIOX

NIOX Group (NIOX) Share Price, News & Analysis

NIOX Group logo
GBX 68.80 +1.40 (+2.08%)
As of 06/13/2025 11:52 AM Eastern

About NIOX Group Stock (LON:NIOX)

Key Stats

Today's Range
68.80
69.80
50-Day Range
55.90
72.80
52-Week Range
53.40
80
Volume
87,323 shs
Average Volume
1.27 million shs
Market Capitalization
£28.26 billion
P/E Ratio
2,839.26
Dividend Yield
1.45%
Price Target
GBX 90
Consensus Rating
Buy

Company Overview

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.

Receive NIOX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NIOX Group and its competitors with MarketBeat's FREE daily newsletter.

NIOX Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
Big Technologies PLC
UK Penny Stocks With Market Caps Below £2B
Niox Group Regulatory News
See More Headlines

NIOX Stock Analysis - Frequently Asked Questions

NIOX Group's stock was trading at GBX 63 at the beginning of 2025. Since then, NIOX shares have increased by 9.2% and is now trading at GBX 68.80.
View the best growth stocks for 2025 here
.

NIOX Group Plc (LON:NIOX) posted its earnings results on Tuesday, April, 1st. The company reported $2.27 earnings per share (EPS) for the quarter. NIOX Group had a trailing twelve-month return on equity of 13.29% and a net margin of 28.21%.

Shares of NIOX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that NIOX Group investors own include Petrofac (PFC), MICT (MICT), Chemring Group (CHG) and N Brown Group (BWNG).

Company Calendar

Last Earnings
4/01/2025
Today
6/15/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
LON:NIOX
CIK
N/A
Fax
N/A
Employees
92
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 90
High Stock Price Target
GBX 90
Low Stock Price Target
GBX 90
Potential Upside/Downside
+30.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
2,839.26
Forward P/E Ratio
59.01
P/E Growth
N/A
Net Income
£995.88 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£3.53 billion
Cash Flow
GBX 6.14 per share
Price / Cash Flow
11.21
Book Value
GBX 18.03 per share
Price / Book
3.82

Miscellaneous

Outstanding Shares
41,071,615,003
Free Float
N/A
Market Cap
£28.26 billion
Optionable
Not Optionable
Beta
0.92
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (LON:NIOX) was last updated on 6/15/2025 by MarketBeat.com Staff
From Our Partners